Vimarsana
Biggest News Aggregation in the World

Innate Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Innate Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Innate Pharma Today - Breaking & Trending Today

Head-To-Head Comparison: Innate Pharma (NASDAQ:IPHA) and Vitro Diagnostics (OTCMKTS:VODG) - Vimarsana News

Head-To-Head Comparison: Innate Pharma (NASDAQ:IPHA) and Vitro Diagnostics (OTCMKTS:VODG)

Innate Pharma (NASDAQ:IPHA – Get Free Report) and Vitro Diagnostics (OTCMKTS:VODG – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk. Institutional & Insider Ownership 0.2% of Innate Pharma […]

Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conferences - Vimarsana News

Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conferences

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced members of its executive team are scheduled to participate in the upcoming conferences

Gritstone bio (NASDAQ:GRTS) versus Innate Pharma (OTCMKTS:IPHYF) Critical Review - Vimarsana News

Gritstone bio (NASDAQ:GRTS) versus Innate Pharma (OTCMKTS:IPHYF) Critical Review

Innate Pharma (OTCMKTS:IPHYF – Get Free Report) and Gritstone bio (NASDAQ:GRTS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, valuation and analyst recommendations. Valuation and Earnings This table compares Innate […]

Innate Pharma SA: Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting - Vimarsana News

Innate Pharma SA: Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting

Top line results of TELLOMAK Phase 2 trial in mycosis fungoides confirming promising clinical activity of lacutamab Two posters on IPH6501, Innate's second generation ANKET, for the treatment

Innate Pharma : 5 abstracts concernant des candidats-médicaments d'Innate ont été sélectionnés pour le congrès annuel de l'ASCO - Vimarsana News

Innate Pharma : 5 abstracts concernant des candidats-médicaments d'Innate ont été sélectionnés pour le congrès annuel de l'ASCO

Innate Pharma SA annonce aujourd'hui que 5 abstracts concernant des candidats-médicaments d'Innate ont été sélectionnés pour le congrès annuel de...